The following is a summary of "Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a ...
A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...
SaltWire on MSN1d
GoFundMe to help Hants County, N.S., teen battling rare bone cancerKalvin is a Grade 12 student at Avon View High School in Windsor.
Jackson Kalbhenn has been cancer-free for almost a year and is now helping other young people who are facing the rare cancer ...
Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its ...
Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...
SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft ...
When cancer has spread to your lungs, treatment can help control and slow ... bone cancer, or soft tissue sarcoma. Lung cancer is the leading cause of cancer deaths in the world.
The Soft Tissue Sarcoma market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032.
Cure Cancer’s campaign is encouraging Australians to turn their next BBQ into a BarbeCURE, an opportunity to raise money for cancer research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback